Xenex Announces DEACTIVATE Handheld Disinfection Device; Proven to Destroy SARS-CoV-2 on Surfaces in 30 Seconds

SAN ANTONIO–(BUSINESS WIRE)–Feb 10, 2021–
Xenex Disinfection Services Inc., a world leader in UV technology-based disinfection strategies and solutions, today announced the launch of Deactivate™, a high-powered, handheld LED device designed to quickly disinfect surfaces in confined spaces.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210210005693/en/
The Deactivate handheld disinfection device is portable and adaptable for a variety of applications, allowing operators to quickly disinfect commonly touched areas between use. (Photo: Business Wire)
Xenex is known for its LightStrike ™ Germ-Zapping Robots™, which have been deployed by hundreds of healthcare facilities worldwide for no-touch room disinfection. As a result of the COVID-19 pandemic, LightStrike robots are now used in airports,schools, hotels, sports arenas, police stations and correctional facilities, convention centers, and more to quickly disinfect large rooms and areas.
Recognizing the need for targeted disinfection in small spaces and compact areas, Xenex has launched Deactivate, which utilizes high-powered LEDs to create ultraviolet (UV) light proven to deactivate pathogens, including severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus that causes COVID-19. Deactivate does not require warm-up or cool-down time, and does not leave behind any chemical residue. Post-disinfection, the area is immediately available for use.
“Our mission is to stop the pain and suffering caused by infections by destroying the pathogens that cause them. There are many businesses that need targeted, rapid disinfection, especially compact areas like dental exam rooms, ambulances, office cubicles, and cockpits. We wanted to offer an effective technology for disinfecting small spaces that are hard to clean and that’s what Deactivate provides,” said Irene Hahn, senior vice president of sales and marketing for Xenex.
Evidence-based. Testing performed at the Texas Biomedical Research Institute demonstrated that the Deactivate device achieves a 99% level of disinfection against SARS-CoV-2 in 30 seconds at 1 meter, 99% against vegetative bacteria (methicillin-resistant Staphylococcus aureus – also known as MRSA, Escherichia coli – also known as E.coli) in 1 minute at 1 meter, and 99% against bacterial spores in 2 minutes at 1 meter.
About Xenex Disinfection Services
Xenex is a world leader in UV technology-based disinfection strategies and solutions. Frost & Sullivan named Xenex the 2020 Global Company of the Year for its patented technology and being at the vanguard of the fight against SARS-CoV-2. Xenex’s mission is to save lives and reduce suffering by destroying the deadly microorganisms that can cause infections. Xenex is backed by well-known investors that include EW Healthcare Partners, Piper Sandler, Malin Corporation, Battery Ventures, Targeted Technology Fund II, Tectonic Ventures and RK Ventures. For more information, visit xenex.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20210210005693/en/
CONTACT: Melinda Hart
Xenex
210 240 4669
Melinda.hart@xenex.com
KEYWORD: TEXAS UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: INFECTIOUS DISEASES HOSPITALS HEALTH MEDICAL DEVICES
SOURCE: Xenex Disinfection Services Inc.
Copyright Business Wire 2021.
PUB: 02/10/2021 10:55 AM/DISC: 02/10/2021 10:55 AM
http://www.businesswire.com/news/home/20210210005693/en